Targeting IL-23 for IBD: Rationale and Progress to Date
Sudheer K. Vuyyuru, Lisa M. Shackelton, Jurij Hanžel, Christopher Ma, Vipul Jairath, Brian G. Feagan
Topics & Concepts
MedicineUstekinumabUlcerative colitisInterleukin 23Inflammatory bowel diseaseCrohn's diseasePsoriasisDiseaseImmunologyClinical trialInternal medicineGastroenterologyImmune systemInterleukin 17AdalimumabPsoriasis: Treatment and PathogenesisInflammatory Bowel DiseaseWhipple's Disease and Interleukins